Interaction of bumetanide derivatives with hepatocellular bile acid uptake

1993 ◽  
Vol 265 (5) ◽  
pp. G942-G954
Author(s):  
E. Petzinger ◽  
W. Follmann ◽  
M. Blumrich ◽  
R. Schermuly ◽  
S. Schulz ◽  
...  
Keyword(s):  
Bile Acid ◽  
Bile Acids ◽  
Model Building ◽  
Organic Anion ◽  
Rat Hepatocytes ◽  
Salt Transport ◽  
Acid Uptake ◽  
Ligand Interaction ◽  
Isolated Rat Hepatocytes ◽  
Bile Acid Uptake

The loop diuretic bumetanide is an organic monocarboxylic organic anion assumed to be transported into hepatocytes by a transport system for bile acids. The structural requirements of 22 bumetanide analogues were analyzed for an interaction with bile acid uptake into isolated rat hepatocytes. Whereas bumetanide inhibited the hepatocellular uptake of [14C]cholate to the same degree as its own uptake, derivatization altered affinity and specificity and yielded compounds that selectively inhibited either cholate or taurocholate uptake or uptake of both. No correlation was found between the diuretic potency of bumetanide derivatives, reflecting the affinity to the Na(+)-K(+)-Cl- cotransporter, and their affinity to hepatic bile salt transport. Computer-aided model building combined with the calculation of potential energy maps showed a strictly amphipathic charge separation in bumetanide analogues as in bile acids. Ranking bumetanide compounds by their mean inhibitory concentration values, inhibition constants, and their type of competition, we conclude that at least three binding domains in the proteins are essential for recognition by bile acid transporters, namely two hydrophobic and an anionic side, and that for the anionic binding region a carbonyl atom in the ligands as an electron donor group is sufficient for ligand interaction.

scholarly journals Heterogeneous accumulation of fluorescent bile acids in primary rat hepatocytes does not correlate with their homogenous expression of ntcp

2011 ◽  
Vol 301 (1) ◽  
pp. G60-G68 ◽  
Author(s):  
John W. Murray ◽  
Amar J. Thosani ◽  
Pijun Wang ◽  
Allan W. Wolkoff
Keyword(s):  
Bile Acid ◽  
Bile Acids ◽  
Hela Cells ◽  
Organic Anion ◽  
Fluorescent Microscopy ◽  
Sodium Taurocholate ◽  
Rat Hepatocytes ◽  
Acid Uptake ◽  
Anion Transporter ◽  
Acid Accumulation

Sodium taurocholate-cotransporting polypeptide (ntcp) is considered to be a major determinant of bile acid uptake into hepatocytes. However, the regulation of ntcp and the degree that it participates in the accumulation of specific substrates are not well understood. We utilized fluorescent bile acid derivatives and direct quantitation of fluorescent microscopy images to examine the regulation of ntcp and its role in the cell-to-cell variability of fluorescent bile acid accumulation. Primary-cultured rat hepatocytes rapidly accumulated the fluorescent bile acids, chenodeoxycholylglycylamidofluorescein (CDCGamF), 7-β- nitrobenzoxadiazole 3-α hydroxy 5-β cholan-24-oic acid (NBD-CA), and cholyl-glycylamido-fluorescein (CGamF). However, in stably transfected HeLa cells, ntcp preferred CDCGamF, whereas the organic anion transporter, organic anion transporting polypeptide 1 (oatp1a1), preferred NBD-CA, and neither ntcp nor oatp1a1 showed strong accumulation of CGamF by these methods. Ntcp-mediated transport of CDCGamF was inhibited by taurocholate, cyclosporin, actin depolymerization, and an inhibitor of atypical PKC-ζ. The latter two agents altered the cellular distribution of ntcp as visualized in ntcp-green fluorescent protein-transfected cells. Although fluorescent bile acid accumulation was reproducible by the imaging assays, individual cells showed variable accumulation that was not attributable to changes in membrane permeability or cell viability. In HeLa cells, this was accounted for by variable levels of ntcp, whereas, in hepatocytes, ntcp expression was uniform, and low accumulation was seen in a large portion of cells despite the presence of ntcp. These studies indicate that single-cell imaging can provide insight into previously unrecognized details of anion transport in the complex environment of polarized hepatocytes.

Amino acid inhibition of bile acid uptake by isolated rat hepatocytes: relationship to dissipation of transmembrane Na+ gradient

1983 ◽  
Vol 245 (3) ◽  
pp. G399-G403
Author(s):  
B. L. Blitzer ◽  
S. L. Ratoosh ◽  
C. B. Donovan
Keyword(s):  
Amino Acids ◽  
Bile Acid ◽  
Amino Acid ◽  
Rat Hepatocytes ◽  
Acid Uptake ◽  
Hepatic Transport ◽  
Transport Pathway ◽  
Isolated Rat Hepatocytes ◽  
Bile Acid Uptake ◽  
Isolated Rat

The effects of amino acids on bile acid uptake were studied in isolated rat hepatocytes. The Na+-dependent amino acid L-alanine inhibited [14C]taurocholate uptake in a nonlinear fashion (IC50, approximately 7 mM). Kinetic studies showed that alanine (30 mM) reduced the Vmax for taurocholate uptake from 1.7 +/- 0.1 to 1.1 +/- 0.1 nmol . mg protein-1 . min-1 but did not significantly affect taurocholate Km (42 +/- 7 vs. 35 +/- 7 microM). Taurocholate uptake was also inhibited by alpha-methylaminoisobutyric acid (which shares a common Na+-dependent transport pathway with alanine but is not metabolized) and by L-glutamine (undergoes Na+-dependent hepatic uptake via a carrier distinct from that for alanine). In contrast, the Na+-independent amino acid 2-aminobicyclo(2,2,1)heptane-2-carboxylic acid had no effect on hepatocyte bile acid uptake. Alanine induced a twofold elevation of intracellular sodium concentration as determined by the steady-state uptake of 22Na. These findings suggest that Na+-dependent amino acids noncompetitively inhibit hepatocyte taurocholate uptake by dissipating the transmembrane Na+ gradient and thereby reduce the driving forces for Na+-coupled bile acid entry. Dissipation of the Na+ gradient by substrates that undergo Na+-dependent hepatic transport may represent a novel mechanism of bile secretory failure.

scholarly journals Taurolithocholate and taurolithocholate 3-sulphate exert different effects on cytosolic free Ca2+ concentration in rat hepatocytes

1994 ◽  
Vol 300 (2) ◽  
pp. 383-386 ◽  
Author(s):  
I Marrero ◽  
A Sanchez-Bueno ◽  
P H Cobbold ◽  
C J Dixon
Keyword(s):  
Bile Acid ◽  
Bile Acids ◽  
Rat Hepatocytes ◽  
Signalling Pathway ◽  
Common Mechanism ◽  
Isolated Rat Hepatocytes ◽  
Isolated Rat

Single rat hepatocytes show repetitive oscillations in cytosolic free Ca2+ concentration ([Ca2+]i) when stimulated by agonists acting through the phosphoinositide signalling pathway. We have studied the effect of a natural bile acid, taurolithocholate (TLC), and its sulphated form, taurolithocholate 3-sulphate (TLC-S), on [Ca2+]i in single isolated rat hepatocytes. Although these bile acids are believed to act through a common mechanism to permeabilize the intracellular Ca2+ pool, the [Ca2+]i responses induced by the two compounds were different. Whereas TLC induced a sustained elevation of [Ca2+]i, TLC-S evoked repetitive [Ca2+]i oscillations. In addition, we show that ryanodine, which blocks the Ca(2+)-induced Ca2+ release (‘CICR’) mechanism, blocked TLC-S-induced oscillations in 50% of hepatocytes, but did not affect the TLC-induced rise in [Ca2+]i.

Effects of gut hormones on bile acid uptake and release in cultured rat hepatocytes

1987 ◽  
Vol 22 (2) ◽  
pp. 174-178 ◽  
Author(s):  
Ichiro Shimizu ◽  
Meisei Hirota ◽  
Mitsuhiro Matsumura ◽  
Kenji Shima
Keyword(s):  
Bile Acid ◽  
Gut Hormones ◽  
Rat Hepatocytes ◽  
Acid Uptake ◽  
Bile Acid Uptake ◽  
Cultured Rat Hepatocytes ◽  
Uptake And Release

scholarly journals Bile Acid Uptake Transporters as Targets for Therapy

2017 ◽  
Vol 35 (3) ◽  
pp. 251-258 ◽  
Author(s):  
Davor Slijepcevic ◽  
Stan F.J. van de Graaf
Keyword(s):  
Bile Acid ◽  
Bile Acids ◽  
Energy Homeostasis ◽  
Sodium Taurocholate ◽  
Hepatic Uptake ◽  
Farnesoid X Receptor ◽  
Acid Uptake ◽  
Bile Acid Uptake ◽  
Uptake Transporters ◽  
Conjugated Bile Acids

Background: Bile acids are potent signaling molecules that regulate glucose, lipid and energy homeostasis predominantly via the bile acid receptors farnesoid X receptor (FXR) and transmembrane G protein-coupled receptor 5 (TGR5). The sodium taurocholate cotransporting polypeptide (NTCP) and the apical sodium dependent bile acid transporter (ASBT) ensure an effective circulation of (conjugated) bile acids. The modulation of these transport proteins affects bile acid localization, dynamics and signaling. The NTCP-specific pharmacological inhibitor myrcludex B inhibits hepatic uptake of conjugated bile acids. Multiple ASBT-inhibitors are already in clinical trials to inhibit intestinal bile acid uptake. Here, we discuss current insights into the consequences of targeting bile acid uptake transporters on systemic and intestinal bile acid dynamics and discuss the possible therapeutic applications that evolve as a result.

Sign in / Sign up

Export Citation Format

Share Document